These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24276520)

  • 1. Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations.
    Di Toro Mammarella L; Mignarri A; Battisti C; Monti L; Bonifati V; Rasi F; Federico A
    J Neurol; 2014 Jan; 261(1):227-8. PubMed ID: 24276520
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.
    Quadri M; Federico A; Zhao T; Breedveld GJ; Battisti C; Delnooz C; Severijnen LA; Di Toro Mammarella L; Mignarri A; Monti L; Sanna A; Lu P; Punzo F; Cossu G; Willemsen R; Rasi F; Oostra BA; van de Warrenburg BP; Bonifati V
    Am J Hum Genet; 2012 Mar; 90(3):467-77. PubMed ID: 22341971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity.
    Leyva-Illades D; Chen P; Zogzas CE; Hutchens S; Mercado JM; Swaim CD; Morrisett RA; Bowman AB; Aschner M; Mukhopadhyay S
    J Neurosci; 2014 Oct; 34(42):14079-95. PubMed ID: 25319704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations.
    DeWitt MR; Chen P; Aschner M
    Biochem Biophys Res Commun; 2013 Mar; 432(1):1-4. PubMed ID: 23357421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC30A10 Mutation Involved in Parkinsonism Results in Manganese Accumulation within Nanovesicles of the Golgi Apparatus.
    Carmona A; Zogzas CE; Roudeau S; Porcaro F; Garrevoet J; Spiers KM; Salomé M; Cloetens P; Mukhopadhyay S; Ortega R
    ACS Chem Neurosci; 2019 Jan; 10(1):599-609. PubMed ID: 30272946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish slc30a10 deficiency revealed a novel compensatory mechanism of Atp2c1 in maintaining manganese homeostasis.
    Xia Z; Wei J; Li Y; Wang J; Li W; Wang K; Hong X; Zhao L; Chen C; Min J; Wang F
    PLoS Genet; 2017 Jul; 13(7):e1006892. PubMed ID: 28692648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.
    Tuschl K; Clayton PT; Gospe SM; Gulab S; Ibrahim S; Singhi P; Aulakh R; Ribeiro RT; Barsottini OG; Zaki MS; Del Rosario ML; Dyack S; Price V; Rideout A; Gordon K; Wevers RA; Chong WK; Mills PB
    Am J Hum Genet; 2012 Mar; 90(3):457-66. PubMed ID: 22341972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of dystonia with polycythemia and hypermanganesemia caused by SLC30A10 mutation: a treatable inborn error of manganese metabolism.
    Tavasoli A; Arjmandi Rafsanjani K; Hemmati S; Mojbafan M; Zarei E; Hosseini S
    BMC Pediatr; 2019 Jul; 19(1):229. PubMed ID: 31288771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.
    Stamelou M; Tuschl K; Chong WK; Burroughs AK; Mills PB; Bhatia KP; Clayton PT
    Mov Disord; 2012 Sep; 27(10):1317-22. PubMed ID: 22926781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations.
    Sammler EM; Swingler RJ; Stuart A; Muqit M
    Mov Disord; 2009 Dec; 24(16):2442-3. PubMed ID: 19891003
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system.
    Marti-Sanchez L; Ortigoza-Escobar JD; Darling A; Villaronga M; Baide H; Molero-Luis M; Batllori M; Vanegas MI; Muchart J; Aquino L; Artuch R; Macaya A; Kurian MA; Dueñas P
    Orphanet J Rare Dis; 2018 Jan; 13(1):28. PubMed ID: 29382362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies.
    Rodan LH; Hauptman M; D'Gama AM; Qualls AE; Cao S; Tuschl K; Al-Jasmi F; Hertecant J; Hayflick SJ; Wessling-Resnick M; Yang ET; Berry GT; Gropman A; Woolf AD; Agrawal PB
    Mol Genet Metab; 2018 Jun; 124(2):161-167. PubMed ID: 29685658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14.
    Mukhopadhyay S
    Neurotoxicology; 2018 Jan; 64():278-283. PubMed ID: 28789954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermanganesemia with Dystonia, Polycythemia and Cirrhosis (HMDPC) due to mutation in the SLC30A10 gene.
    Mukhtiar K; Ibrahim S; Tuschl K; Mills P
    Brain Dev; 2016 Oct; 38(9):862-5. PubMed ID: 27117033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Elements in the Transmembrane and Cytoplasmic Domains of the Metal Transporter SLC30A10 Are Required for Its Manganese Efflux Activity.
    Zogzas CE; Aschner M; Mukhopadhyay S
    J Biol Chem; 2016 Jul; 291(31):15940-57. PubMed ID: 27307044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.
    Tuschl K; Meyer E; Valdivia LE; Zhao N; Dadswell C; Abdul-Sada A; Hung CY; Simpson MA; Chong WK; Jacques TS; Woltjer RL; Eaton S; Gregory A; Sanford L; Kara E; Houlden H; Cuno SM; Prokisch H; Valletta L; Tiranti V; Younis R; Maher ER; Spencer J; Straatman-Iwanowska A; Gissen P; Selim LA; Pintos-Morell G; Coroleu-Lletget W; Mohammad SS; Yoganathan S; Dale RC; Thomas M; Rihel J; Bodamer OA; Enns CA; Hayflick SJ; Clayton PT; Mills PB; Kurian MA; Wilson SW
    Nat Commun; 2016 May; 7():11601. PubMed ID: 27231142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile parkinsonism-dystonia due to dopamine transporter gene mutations: another genetic twist.
    Blackstone C
    Lancet Neurol; 2011 Jan; 10(1):24-5. PubMed ID: 21112252
    [No Abstract]   [Full Text] [Related]  

  • 18. Manganese transport disorder: novel SLC30A10 mutations and early phenotypes.
    Quadri M; Kamate M; Sharma S; Olgiati S; Graafland J; Breedveld GJ; Kori I; Hattiholi V; Jain P; Aneja S; Kumar A; Gulati P; Goel M; Talukdar B; Bonifati V
    Mov Disord; 2015 Jun; 30(7):996-1001. PubMed ID: 25778823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Neurologic Phenotype and Novel SLC30A10 Mutation in Two Brothers with Hereditary Hypermanganesemia.
    Gulab S; Kayyali HR; Al-Said Y
    Neuropediatrics; 2018 Feb; 49(1):72-75. PubMed ID: 29179235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopathy and parkinsonism in phosphoglycerate kinase deficiency.
    Sotiriou E; Greene P; Krishna S; Hirano M; DiMauro S
    Muscle Nerve; 2010 May; 41(5):707-10. PubMed ID: 20151463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.